Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2014
02/12/2014EP2694545A1 BISPECIFIC BINDING MOLECULES BINDING TO Dll4 AND Ang2
02/12/2014EP2694544A2 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
02/12/2014EP2694543A2 Single chain antibodies for photosynthetic microorganisms and methods of use
02/12/2014EP2694542A2 Herpes simplex virus
02/12/2014EP2694541A1 Antibody product comprising n specific antibodies
02/12/2014EP2694540A2 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
02/12/2014EP2694539A1 Polyclonal antibody compositions
02/12/2014EP2694108A2 Methods for treating conditions associated with masp-2 dependent complement activation
02/12/2014EP2694100A1 Formulations with reduced viscosity
02/12/2014CN103582651A Monoclonal antibody capable of recognizing human papilloma virus (HPV) L2 protein, and method for measuring HPV-neutralizing antibody titer using same
02/12/2014CN103582650A Method for preparing Fc-containing polypeptides having improved properties
02/12/2014CN103582492A Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
02/12/2014CN103575889A Test strip and method for detecting vancomycin
02/12/2014CN103571796A Chicken interleukin-10 monoclonal antibodies and preparation method and application thereof
02/12/2014CN103570833A Human lactoferrin monoclonal antibody, and preparation method and application thereof
02/12/2014CN103570832A Anti-Haemophilus parasuis porcine chimeric antibody, and construction method and application thereof
02/12/2014CN103570831A Bovine-derived anti-staphylococcus aureus single-chain antibody as well as preparation method and application thereof
02/12/2014CN103570830A Preparation method of anti-canine parvovirus protein VP2 specific IgY
02/12/2014CN103570829A Method for extracting gamma-livetin (IgY) from yolk
02/12/2014CN102936286B Anti-anthrax PA antigen monoclonal antibody and applications thereof
02/12/2014CN102238962B Anti-ferroportin 1 monoclonal antibodies and uses thereof
02/12/2014CN102197052B High affinity human antibodies to human IL-4 receptor
02/12/2014CN101918442B Anti-VEGF antibodies
02/12/2014CN101704892B Anti-uPAR humanized antibody, coding gene and application thereof
02/12/2014CN101702906B Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
02/12/2014CN101309934B 修饰的伴侣蛋白10 Modified chaperonin 10
02/12/2014CN101147063B 5-fluoro-uracil immunoassay
02/11/2014US8648182 Polynucleotides encoding antibodies to cytokine receptor zcytor17
02/11/2014US8648177 Lyophilization methods, compositions, and kits
02/11/2014US8648176 Engineered proteins with high affinity for DOTA chelates
02/11/2014US8648175 Stable pharmaceutical composition comprising erythropoietin
02/11/2014US8648174 Ucp4
02/11/2014US8648173 Inhibition of tumor metastasis by anti neuropilin 2 antibodies
02/11/2014US8648172 Anti-MUC1 α/β antibodies
02/11/2014US8648171 Members of the FC receptor homolog gene family (FcRH1-3,6) related reagents and uses thereof
02/11/2014US8648170 Peptide-presenting surfaces for long-term culture of pluripotent cells
02/11/2014US8647887 Measuring G protein coupled receptor activation
02/11/2014US8647831 Cobalamin assay
02/11/2014US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
02/11/2014US8647818 Molecular scaffolds for HIV-1 immunogens
02/11/2014US8647630 Mite allergen
02/11/2014US8647625 Anti-CD154 antibodies
02/11/2014US8647624 Treatment of immune disorders with anti-CD70 antibody
02/11/2014CA2634131C Protein formulations with reduced viscosity and uses thereof
02/11/2014CA2623554C Methods and therapies for treating inflammatory conditions with exposed collagen
02/11/2014CA2578341C Determining feline and canine probnp
02/11/2014CA2564098C Solution phase biopanning method using engineered decoy proteins
02/11/2014CA2529496C Anti-cd74 immunoconjugates and methods
02/11/2014CA2471432C Nonhuman model animal lacking the ability to control lymphocyte migration
02/11/2014CA2452946C Detection and diagnosis of transmissible spongiform encephalopathies
02/11/2014CA2421751C Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
02/11/2014CA2387184C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
02/06/2014WO2014022853A1 Complex chromosome engineering for production of human antibodies in transgenic animals
02/06/2014WO2014022758A1 Single agent anti-pd-l1 and pd-l2 dual binding antibodies and methods of use
02/06/2014WO2014022679A2 Anti-etbr antibodies and immunoconjugates
02/06/2014WO2014022592A1 Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece
02/06/2014WO2014022540A1 Multivalent antigen-binding proteins
02/06/2014WO2014021693A2 Novel monoclonal antibody which is specifically bound to tm4sf5 protein and use thereof
02/06/2014WO2014021339A1 Monoclonal antibody against human midkine
02/06/2014WO2014020922A1 Antibody and functional fragment thereof capable of treating diseases associated with hematopoietic stem cell transplantation such as graft-versus-host disease, and pharmaceutical composition comprising same
02/06/2014WO2014020331A1 Therapeutic and diagnostic target
02/06/2014WO2014020184A1 Means for treating heart disease
02/06/2014WO2014020140A1 Use of transferrin receptor antagonist for the treatment of thalassemia
02/06/2014WO2014020139A1 Method of generating antibodies
02/06/2014WO2014020062A1 Novel anti-plasmodium parasite antibodies
02/06/2014WO2014019727A1 Anti-fcrn antibodies
02/06/2014WO2014019644A1 Selective measurement of active human protease coagulation factors
02/06/2014WO2013166594A8 Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domain
02/06/2014WO2013004076A8 Agr2 blocking antibody and use thereof
02/06/2014US20140041068 Methods of Modifying Eukaryotic Cells
02/06/2014US20140039165 Anti-nr10 antibody and use thereof
02/06/2014US20140039164 Therapeutic human anti-il-1r1 monoclonal antibody
02/06/2014US20140039163 Cholesterol-dependent cytolysin variant and use thereof in dds
02/06/2014US20140039162 Displaying native human IgE neutralizing FceRla-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold
02/06/2014US20140039161 METHOD FOR EXTRACTING IgY (r-LIVETIN) FROM EGG YOLK
02/06/2014US20140039155 Amyloid-beta peptide crystal structure
02/06/2014US20140038842 Cell surface display using pdz domains
02/06/2014US20140038287 Fc Receptor-Binding Polypeptides with Modified Effector Functions
02/06/2014US20140038234 Expression System With Sar Element From IFNalpha2
02/06/2014US20140038210 ANTI-HUMAN IgG1 ANTIBODY
02/06/2014US20140037717 Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1
02/06/2014US20140037667 Rapid selection method for hiv gp-120 variants
02/06/2014US20140037664 Protein for use as a medicament
02/06/2014US20140037651 Depleted anti-staphylococcal enterotoxins polyclonal antibodies, preparation and uses thereof
02/06/2014US20140037650 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
02/06/2014US20140037648 Antibodies that neutralize rsv, mpv and pvm and uses thereof
02/06/2014US20140037646 Mmp8 inactivating antigen binding proteins
02/06/2014US20140037643 Anti-notch2 nrr antibodies
02/06/2014US20140037641 Peptide and Conjugate Vaccines for Fungal Infections
02/06/2014US20140037639 LINGO Binding Molecules and Pharmaceutical Use Thereof
02/06/2014US20140037638 Compositions and methods for treating amyloid plaque associated symptoms
02/06/2014US20140037637 Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)
02/06/2014US20140037636 Anti-cd98 antibody processes
02/06/2014US20140037635 Methods of treatment using il-17e antagonists
02/06/2014US20140037634 Regulatory t cell mediator proteins and uses thereof
02/06/2014US20140037632 Multi-specific antigen-binding molecules and uses thereof
02/06/2014US20140037631 Antigen binding formats for use in therapeutic treatments or diagnostic assays
02/06/2014US20140037629 Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis
02/06/2014US20140037628 Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
02/06/2014US20140037624 Anti-fgfr4 antibodies and methods of use
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 1494